Breaks Categories: News

TuesdayFeb 14, 2023 11:42 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Launches New Program Targeting Unmet Medical Needs for Alcohol Misuse

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders. The company today announced the launch of a new research and development program focused on unmet medical needs for alcohol misuse. “Alcohol intoxication is a common presentation in many patients who visit hospital emergency rooms, and I see this during every one of my shifts,” said Dr. Albert Wong, a member of FSD Pharma’s expert advisory committee and a psychiatrist in the emergency department at the Centre…

Continue Reading

TuesdayFeb 14, 2023 11:32 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q3 Financial Report, Corporate Highlights

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is reporting on its third quarter performance as well as recent business highlights; the report is for the period ended Dec. 31, 2022. In the report, the company noted that it had received approval from an independent ethics committee in the Netherlands to begin the first-in-human dosing of its CYB004 through a protocol amendment to its ongoing phase 1 CYB004-E trial; CYB004 is the company’s proprietary deuterated N,N-dimethyltryptamine (“DMT”) molecule. The company is also making progress on its phase 1/2a clinical trial evaluating CYB003 for the potential treatment…

Continue Reading

TuesdayFeb 14, 2023 11:15 am

NetworkNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Promising Data for Casiterita and Iska Iska Properties

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced results of additional modeling of ground magnetic data and completion of an initial Induced Polarization/Resistivity survey (“IP/Res”) on the Casiterita property adjoining the Iska Iska Silver-Tin Polymetallic property to the southwest. The new data, combined with previous magnetic modeling and borehole IP/Res surveys (“BHIP”) on Iska Iska, have significantly enhanced the understanding of the overall geological environment on both properties and outlined major new targets for exploration on the optioned Casiterita. “Geophysics continues to be a very effective exploration tool at Iska Iska and now at the Casiterita property,” said…

Continue Reading

TuesdayFeb 14, 2023 10:48 am

NetworkNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Shares Details on Proposed Public Offering

CISO Global Inc. (NASDAQ: CISO), formerly Cerberus Cyber Sentinel Corp., an industry leader in global cybersecurity and compliance services based in Scottsdale, Arizona, today commenced an underwritten public offering of its common stock, with Cantor Fitzgerald & Co. acting as the sole book-running manager. According to the release, the company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. CISO aims to utilize proceeds from the offering toward a variety of general corporate purposes, including working capital, capital expenditures, repayment and refinancing…

Continue Reading

TuesdayFeb 14, 2023 10:38 am

NetworkNewsBreaks – Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) Releases Pricing of Underwritten Public Offering to Total Estimated $15M

Sonnet BioTherapeutics (NASDAQ: SONN), a clinical-stage company developing innovative targeted biologic drugs, is reporting the pricing of its underwritten public offering; the offering consists of 13,888,888 shares of common stock or common stock equivalents, including prefunded warrants to purchase shares of common stock in lieu of shares of common stock and investor warrants to purchase up to an aggregate of 27,777,776 shares of common stock. According to the announcement, the common stock shares (or prefunded warrants in lieu thereof) are being combined and sold with one investor warrant enabling the purchase of two shares of common stock at a combined…

Continue Reading

MondayFeb 13, 2023 12:46 pm

NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Alzheimer’s

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has filed a provisional patent application for the use of its central nervous system (“CNS”) homing peptides to treat Alzheimer’s disease and the onset of dementia. Alzheimer’s has proven to be a progressive neurodegenerative disorder associated with the destruction of higher brain structures, such as those involved in cognition and memory function. The disease leads to declines and deficits in memory, learning, language and the ability to perform intentional and purposeful movements and is accompanied by concomitant behavioral, emotional,…

Continue Reading

MondayFeb 13, 2023 12:31 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Completes Acquisition of the Bahia Project

Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced completion of its acquisition of 17 mineral concessions between the towns of Prado and Caravelas in the state of Bahia, Brazil, totaling 15,089.71 hectares (approximately 37,300 acres or 58.3 square miles). According to the announcement, closing of the “Bahia Project” followed the Brazilian Government’s approval of the transfers to Energy Fuels’ wholly owned Brazilian subsidiary Energy Fuels Brazil, Ltda. At the closing, Energy Fuels paid the mineral owners the remaining $21.9 million cash. “Energy Fuels has achieved yet another important milestone for our expanding rare earth business through our acquisition of…

Continue Reading

MondayFeb 13, 2023 11:56 am

NetworkNewsBreaks – Electronic Servitor Publication Network Inc. (XESP) Names New President

Electronic Servitor Publication Network (OTCQB: XESP), a managed digital engagement solutions company, announced the appointment of a seasoned veteran as its new president and CEO. Peter Hager, who has an impressive three-decade track record of cross-industry experience, will be taking over leadership of the company. Hager comes from Pointward Inc., a medtech customer agency company that he founded, which provided business solutions to drive market entry, commercialization, and growth for Fortune 500 healthcare brands and medtech startups looking to improve the quality of healthcare. Prior to that, Hager founded and served as a director for several technology, professional services and…

Continue Reading

MondayFeb 13, 2023 9:30 am

NetworkNewsBreaks – Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) CEO Featured on Gamechangers LIVE(R)

Cerberus Sentinel (NASDAQ: CISO) founder and CEO David Jemmett was featured on a recent episode of Gamechangers LIVE(R) with host Sergio Tigera. The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspectives on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. In the episode, Jemmett discusses his extensive background in the field and the origins of Cerberus Sentinel, an industry leader in cybersecurity and compliance services that leverages an integrated approach to reduce noise and bridge common silos that often limit the effectiveness of cybersecurity programs. “If…

Continue Reading

FridayFeb 10, 2023 3:00 pm

NetworkNewsBreaks – Tenax Therapeutics Inc. (NASDAQ: TENX) Announces $15.6M Public Offering

Tenax Therapeutics (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced the pricing of a public offering of 8,666,666 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 17,333,332 shares of its common stock at a purchase price of $1.80 per share and associated public warrant. According to the announcement, the public warrants will have an exercise price of $2.25 per share, are immediately exercisable and will expire five years after their initial exercise date. Roth…

Continue Reading